Skip to content
Governance Register

← US public companies

Ventyx Biosciences, Inc.

SEC CIK 1851194 · VTYX · last insider filing 2026-03-04

Directors (from insider filings)

NameCapacity as filedFilings
Subramaniam Somu Director filed 2021 - 2026
Hulme Allison Director filed 2023 - 2026
Gujrathi Sheila Director filed 2021 - 2026
White William Richard Director filed 2021 - 2026
Cadoret-Manier Onaiza Director filed 2023 - 2026
Mohan Raju Director · Chief Executive Officer filed 2021 - 2026
Royston Aaron Director filed 2021 - 2023
Choksey Jigar Director filed 2021 - 2022
Gaster Richard Director filed 2021 - 2022

Officers (from insider filings)

NameTitle as filedFilings
Moore Matthew Richard Chief Operating Officer filed 2024 - 2026
Nuss John Chief Scientific Officer filed 2021 - 2026
Forman Mark S Chief Medical Officer filed 2024 - 2026
Gonzales Roy Senior VP, Finance filed 2024 - 2026
Krueger Christopher W Chief Business Officer filed 2021 - 2024
Auster Martin Chief Financial Officer filed 2021 - 2024
Sandborn William J. See Remarks filed 2022 - 2023
Drappa Jorn Chief Medical Officer filed 2021 - 2022

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.